Navigation Links
Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
Date:12/12/2007

spinal company that designs, manufactures, markets and distributes a comprehensive and innovative range of quality spinal devices. Based in Orlando, Florida, Scient'x USA offers a range of products to treat conditions such as lumbar instability, trauma, and degenerative disc disease. Scient'x USA has become known for producing and marketing the "Isobar TTL Dynamic Spine Stabilization System" and continues to develop new products in conjunction with surgeon physicians for the Orthopaedic and Neurological community. For more information visit http://www.scientxusa.com.

Except for the historical information contained herein, the matters discussed are forward looking statements made pursuant to the safe harbor provisions of the private securities litigation form act of 1995. These statements involved risks and uncertainties, such as regulatory approvals, manufacturing uncertainties, the impacts of competitive products and pricing, and other risks and uncertainties set forth.


'/>"/>
SOURCE Scient'x USA
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Kenyan malaria success strengthens call for free insecticide-treated nets for all
2. International study strengthens case for daily calcium pill
3. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
4. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
7. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
8. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
9. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
10. Yakima Health Care Leader Tapped for Leadership Post at National Association
11. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/21/2010)... the House is expected to approve today, according to Congressman Chaka Fattah (D-PA-02). , ... , ... ... ... "Small businesses are major employers and the backbone of our ...
(Date:3/18/2010)... ... for cosmetic and plastic surgery patients. The Plastic Surgery Institute of Southeast Texas provides their ... ... and well-used in cosmetic surgery procedures. It is also one of the top concerns for ...
(Date:3/18/2010)... March 24 as they join thousands of young people nationwide for the 15th annual Kick Butts Day.  More than 1,000 events are planned in all 50 states ... ... ... ...
(Date:3/18/2010)... Prevention Initiatives , ... , ... ... WASHINGTON , March 18 Kids in Montana will take center ...
(Date:3/18/2010)... LOS ANGELES Physician scientists from the Cedars-Sinai Heart ... aspirin therapy for preventing heart disease, a drug therapy ... devices (LVADs) may play in weight reduction for obese ... for heart transplantation. These presentations were made at ...
Breaking Medicine News(10 mins):Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 2Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 3Health News:Plastic Surgery Institute of Southeast Texas Offers Milder Anesthesia for Outpatient Procedures 2Health News:Nevada Kids 'Kick Butts' on March 24 2Health News:Nevada Kids 'Kick Butts' on March 24 3Health News:Nevada Kids 'Kick Butts' on March 24 4Health News:Montana Kids 'Kick Butts' on March 24 2Health News:Montana Kids 'Kick Butts' on March 24 3Health News:Montana Kids 'Kick Butts' on March 24 4Health News:Montana Kids 'Kick Butts' on March 24 5Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 2Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 3
... average gym-goer, studies show , , FRIDAY, Nov. 14 (HealthDay News) -- ... bar or sports drink soon after a workout. , But for ... weight in check or stave off heart disease -- adding calories ... sweat, researchers say. , "If people are going to go out ...
... journal published by The Feinstein Institute for ... functioning and disease pathogenesis at the molecular ... to use that knowledge in the design ... treatment, prognosis, and prevention. Featured in ...
... debilitating diseases known to man, and new findings about Alzheimer,s disease ... To read the entire report about the latest in these ... ... Boca Raton, Fla. (PRWEB) November 14, 2008 -- It,s one ...
... that provides comprehensive services to low-income children and ... some aspects of school readiness, but not others. ... to make it easier to integrate research into ... children in both academic and social-emotional areas. , ...
... problems and experiences early in life lead to serious ... has found that the answer may lie in a ... behaviors and new experiences that lead to yet other ... researchers found that children who had social and academic ...
... Nov. 13 On Thursday, Nov. 13, 2008,Cleveland Indians pitcher ... remarkable 22-3 season, Lee was a favorite to win the,prestigious ... the field. For the past three years,he and his wife, ... Society,s (LLS) Northern Ohio Chapter Light The Night(TM) Walk.,This annual ...
Other Medicine News:Health News:Post-Workout Snack May Hamper Weight Loss 2Health News:Post-Workout Snack May Hamper Weight Loss 3Health News:Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage, 2Health News:Alzheimer's Disease Cutting Edge Research Announced on Natural Health News Report Website 2Health News:Research-based program found to enhance impact of Head Start on school readiness 2Health News:Cascading effect of even minor early problems may explain serious teen violence 2Health News:The Leukemia & Lymphoma Society Congratulates Cy Young Award Winner Cliff Lee 2
(Date:3/18/2010)... March 18 Jeffrey B. Kindler ... board chairman of the Pharmaceutical Research and Manufacturers of ... Also elected were sanofi-aventis Chief Executive Officer Christopher ... Directors, and John C. Lechleiter , Ph.D., Chairman, ...
(Date:3/18/2010)... LOUISVILLE, Colo. , March 18 ... largest national distributors, and medical-surgical suppliers and group purchasing ... drive visibility and synchronization throughout the contracting process. Historically, ... loaded into the respective systems of all parties to ...
(Date:3/18/2010)... Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today honored Ron and Raychel Bartek for their dedicated work driving awareness of ... ... ... ...
Breaking Medicine Technology:Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8GHX Collaboration Portal Validates Contract Pricing in Real Time; First to be Used by All Stakeholders of the Healthcare Supply Chain 2GHX Collaboration Portal Validates Contract Pricing in Real Time; First to be Used by All Stakeholders of the Healthcare Supply Chain 3GHX Collaboration Portal Validates Contract Pricing in Real Time; First to be Used by All Stakeholders of the Healthcare Supply Chain 4PhRMA Honors Patient Advocates Ron and Raychel Bartek 2PhRMA Honors Patient Advocates Ron and Raychel Bartek 3PhRMA Honors Patient Advocates Ron and Raychel Bartek 4PhRMA Honors Patient Advocates Ron and Raychel Bartek 5PhRMA Honors Patient Advocates Ron and Raychel Bartek 6Sokolove Law Launches Chinese Drywall Consumer Advocacy Hotline 51037 1Sokolove Law Launches Chinese Drywall Consumer Advocacy Hotline 51037 2National Social Security Disability Advocacy Firm Changes Name to 26quot 3BFreedom Disability 26quot 3B and Acquires 22 000 Square Foot Corporate Hea 51035 1National Social Security Disability Advocacy Firm Changes Name to 26quot 3BFreedom Disability 26quot 3B and Acquires 22 000 Square Foot Corporate Hea 51035 2National Social Security Disability Advocacy Firm Changes Name to 26quot 3BFreedom Disability 26quot 3B and Acquires 22 000 Square Foot Corporate Hea 51035 3Perot Systems Selected to Implement Health Information Systems in China 51033 1Perot Systems Selected to Implement Health Information Systems in China 51033 2Perot Systems Selected to Implement Health Information Systems in China 51033 3
... Trial Published in CANCER: the Journal of the ... ... Therapeutics, Inc.,(CTI) (Nasdaq: CTIC ; MTAX) announced today that ... CANCER demonstrate that the,addition of radioimmunotherapy (RIT) to chemotherapy for ...
... Jan. 20 CeloNova BioSciences, Inc.,("CeloNova"), leading ... development of innovative medical devices, has released ... country European study of uterine fibroid,embolization using ... reported at the 20th Annual International Symposium ...
Other Medicine Technology:Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 2Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 5CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids 2
... Completely revised and updated for ... up-to-date guide to all aspects of ... comprehensive, easy to use catalog of ... off label commonly used in cancer ...
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
... information for patients and health consumers from ... Information featured in MedMaster includes why the ... used, potential side effects and warning signs ... dietary instructions, information on what to do ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
Medicine Products: